OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Clinical trials for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT explained in plain language.
Never miss a new study
Get alerted when new OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT trials appear
Sign up with your email to follow new studies for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New obesity drug targets body fat distribution in clinical trial
Disease control OngoingThis study is testing whether an experimental medication called aleniglipron can change body composition in people with obesity. 71 adults with a body mass index of 30 or higher will receive either the drug or a placebo for 40 weeks. Researchers will measure changes in body fat, …
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New obesity drug shows promise in Mid-Stage trial
Disease control OngoingThis study is testing whether an experimental medication called aleniglipron helps people with obesity or overweight lose weight. About 220 participants will receive either the drug or a placebo for 36 weeks, with an option to continue for another 36 weeks. The main goal is to se…
Matched conditions: OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT
Phase: PHASE2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC